News Dec 1, 2015 CardioCell Plans Phase IIb Clinical Trial Using Its Stem Cells for Patients With Chronic Heart Failure CardioCell LLC, a Stemedica Cell Technologies Inc. subsidiary that uses allogeneic stem cells for cardiovascular indications, intends to proceed with finalizing a
Read MoreCardioCell Board Members and Clinical Trial Leads Collaborate On Peer-Reviewed Paper Published In The Journal Of Cardiovascular Medicine
News Oct 21, 2015 CardioCell Board Members and Clinical Trial Leads Collaborate On Peer-Reviewed Paper Published In The Journal Of Cardiovascular Medicine CardioCell LLC, a Stemedica Cell Technologies Inc. subsidiary that uses allogeneic stem cells for cardiovascular indications,
Read MoreCardioCell developing stem cell therapy for chronic heart failure
News May 29, 2015 CardioCell developing stem cell therapy for chronic heart failure San Diego biotech startup CardioCell seems to be progressing nicely in developing a stem cell-based therapy for chronic heart failure. READ FULL ARTICLE
Read MoreCardioCell adds Stony Brook University to sites conducting phase IIa trial
News Mar 12, 2015 CardioCell adds Stony Brook University to sites conducting phase IIa trial CardioCell, a Stemedica Cell Technologies subsidiary that designs allogeneic stem-cell therapies for cardiovascular indications, has expanded patient recruitment to Stony Brook University’s
Read MoreUniversity of Pennsylvania Doses First Patient In Phase IIa Clinical Trial Using CardioCell’s Stem Cell Therapy To Treat Chronic Heart Failure (HF) Due To Non-Ischemic Cardiomyopathy
News Nov 21, 2014 University of Pennsylvania Doses First Patient In Phase IIa Clinical Trial Using CardioCell’s Stem Cell Therapy To Treat Chronic Heart Failure (HF) Due To Non-Ischemic Cardiomyopathy CardioCell LLC, a Stemedica Cell Technologies Inc. subsidiary that creates
Read MoreCardioCell launches trial to assess stem cell therapy for chronic HF
News Sep 1, 2014 CardioCell launches trial to assess stem cell therapy for chronic HF CardioCell announced the initiation of a phase 2a trial of ischemia-tolerant mesenchymal stem cell therapy for patients with chronic HF due to nonischemic cardiomyopathy. READ FULL ARTICLE
Read MoreClinical Trials – Chronic Heart Failure – CardioCell
News Aug 4, 2014 Clinical Trials - Chronic Heart Failure - CardioCell CardioCell began its Phase IIa trial for chronic heart failure patients with non-ischemic cardiomyopathy. FULL ARTICLE APPEARED IN THE AUGUST 2014 PRINT EDITION
Read MoreCardioCell Begins Phase IIa Clinical Trial Using itMSC Therapy to Treat Chronic Heart Failure HF Due to Non-Ischemic Cardiomyopathy
News Jul 23, 2014 CardioCell Begins Phase IIa Clinical Trial Using itMSC Therapy to Treat Chronic Heart Failure HF Due to Non-Ischemic Cardiomyopathy CardioCell LLC, a Stemedica Cell Technologies Inc. subsidiary that creates allogeneic stem-cell therapies for cardiovascular
Read More